Prime Therapeutics (Prime) once again has a robust presence at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston from March 31–April 3. AMCP is the nation’s leading professional association that aims to help patients get the medications they need at a cost they can afford. This event annually attracts more than 4,000 industry leaders, health care professionals and stakeholders committed to advancing the field. Prime’s teams will present research posters and educational sessions on health outcomes research. 

Press release 

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
Prime to present seven studies and receive the 2024 JMCP Award for Excellence
Read more »

Stories

Look for Prime Therapeutics at AMCP 2025
From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights
Read more »

Prime Therapeutics honored with JMCP “Article of the Year” Award for Excellence
Prime’s industry-leading research on GLP-1s was recognized at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston
Read more »
 

Perspectives

Prime Therapeutics GLP-1 research at AMCP offers additional perspectives to obesity treatment
Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members
Read more »

How the Medicare Member Drug Cost Predictive Model can forecast Medicare Part D drug costs
Prime Therapeutics researchers share how the model helps to optimize drug therapy and lower costs
Read more »

Pharmacy residency program offers opportunities to present real-world research at AMCP 2025
Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event
Read more »

ICYMI: Catch up on Prime’s educational sessions from AMCP 2025
Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service
Read more »

Podcast

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025
Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event
Read more »

LISTEN NOW: Decoding health outcomes at AMCP Annual Meeting 2025
Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings
Read more »
 

Research & Publications

Prime Therapeutics presents seven research posters at AMCP Annual Meeting 2025
Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model
Read more »
 

In the news

Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025
A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control group
Read more »

Managed Healthcare Executive: The Impact of Site-Neutral Payment on Healthcare Costs, Patient Access | AMCP Annual 2025
Connie Estep, Pharm.D., BCGP, director of specialty clinical solutions at Prime Therapeutics, presented on legislative impacts on site of service at this year's AMCP meeting in Houston
Read more »

Managed Healthcare Executive: Protecting Patient Access Amid Site of Service Policy Changes | AMCP Annual 2025
At the AMCP 2025 annual meeting, Sean Shirk, Pharm.D., stressed the need for payers to stay informed and engaged with legislation to sustain site-of-service efforts despite growing restrictions
Read more »

Managed Healthcare Executive: What's Ahead for Site-Neutral Payments in Medicare and State Policies | AMCP Annual 2025
Co-presenter, Sean Shirk, Pharm.D., director of specialty clinical solutions at Prime Therapeutics, discussed this topic during a presentation on legislative impacts on site of service at the AMCP 2025 annual meeting in Houston on Tuesday
Read more »